Use of a HIV derived accessory protein for the reactivation of latent HIV
US11098085B2 · kind B2 · utility
0Cited by
1References
14Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 2, 2019 |
| Grant date | Aug 24, 2021 |
| Priority date | — |
| Expiry date | Jul 2, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/16322
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention concerns the use of a protein comprising at least a HIV-derived accessory protein tat (trans-activator of transcription) or any derivative thereof for the reactivation of latent human immunodeficiency virus (HIV) from cells present in a HIV-infected patient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.